Operation of Brain Stimulation Equipment Under Remote Viewing Effectiveness Registry

Launched by BIOMEDICAL DISCOVERIES AND NEUROSCIENTIFIC FOUNDATIONS LLC · Jul 16, 2024

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Have a primary diagnosis of major depressive disorder (MDD) and/or generalized anxiety disorder (GAD)
• • Are receiving outpatient care,
• • Voluntarily provide competent consent for treatment,
• • Are 12 years of age or older,
• • Are able to adhere to the weekly assessment schedule for primary outcome measures,
• • Have been assessed by their prescribing physician as suitable candidates for TMS treatment in terms of safety and presenting indication,
• • Have consented to undergo a therapeutic course of TMS treatment at one of the participating clinic sites,
• • Are able to communicate in the English language.
• Exclusion Criteria:
• • Have been found to have any contraindication to TMS treatment by their prescribing physician,
• • Are considered unsuitable for outpatient care due to illness severity or other factors in the opinion of their prescribing physician,
• • Have active suicidal intent or plan,
• • Are unable to adhere to or decline participation in the weekly assessment schedule for primary outcome measures,
• • Lack the ability to communicate in the English language.